Table 1 Age at diagnosis and age-standardized participant characteristics according to first post-diagnostic aspirin use among 10,705 women diagnosed with breast cancer in the NHS and NHSII

From: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival

Participant characteristics

Post-diagnostic

 

Regular aspirin use (≥2 days/week)

 

Nonuser N = 7122

Aspirin user N = 3583

Age at diagnosis (years) [mean (SD)]

58.3 (10.7)

64.3 (9.8)

Year of diagnosis (years) [mean (SD)]

2000 (9)

2001 (9)

White [%]

97%

98%

Pre-diagnostic regular aspirin use ( ≥2 days/week) [%]

12%

64%

BMI (kg/m2) [mean (SD)]

25.9 (4.9)

26.3 (5.0)

Current smoker [%]

8%

9%

Physical activity (MET-h/week) [mean (SD)]

26.3 (30.7)

24.5 (28.2)

Post-menopausal at diagnosis [%]

72

72

Parous [%]

90

89

Ever use of oral contraceptives [%]

31

33

Ever use of hormone replacement therapy [%]

48

51

Estrogen receptor positive [%]

79

80

Progesterone receptor-positive [%]

67

69

HER2 positive [%]

12

11

Disease stage at diagnosis [%]

 I

56

61

 II

32

31

 III

12

8

Treatment [%]

 Hormone therapy

70

72

 Chemotherapy

4%

44

 Radiation

58

60

History of physician-diagnosed myocardial infarction [%]

1

2

History of physician-diagnosed stroke [%]

1

2

History of physician-diagnosed rheumatoid arthritis [%]

2

1

History of self-reported angina [%]

3

7